Sonoma Pharmaceuticals Inc.’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $1.17 on 07/26/23, with the lowest value being $0.12 on 11/10/23.
52-week price history of SNOA Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Sonoma Pharmaceuticals Inc.’s current trading price is -69.12% away from its 52-week high, while its distance from the 52-week low is 211.73%. The stock’s price range during this period has fluctuated between $0.12 and $1.17. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.64 million for the day, which was evidently lower than the average daily volume of 5.08 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Sonoma Pharmaceuticals Inc. (SNOA) has experienced a quarterly rise of 140.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.86M and boasts a workforce of 172 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1933, with a change in price of +0.2119. Similarly, Sonoma Pharmaceuticals Inc. recorded 3,384,268 in trading volume during the last 100 days, posting a change of +144.74%.
SNOA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SNOA stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.01.
SNOA Stock Stochastic Average
Sonoma Pharmaceuticals Inc.’s raw stochastic average for the past 50 days is currently at 66.04%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 62.94%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 55.22% and 63.88%, respectively.
SNOA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price gain of 100.28% this year. Over the last six months, there has been a weaker performance of 117.39%. The price of SNOA fallen by 77.11% during the last 30 days period. For the last 5-days stocks have slided -7.26%.
